Recruiting
Factor IX deficiency
RecruitingStudy on the Safety and Effectiveness of REGV131 and LNP1265 for Adults with Hemophilia B
InvestigationalNo placebo
Study on the Safety and Effectiveness of REGV131 and LNP1265 for Adults with Hemophilia B
InvestigationalNo placebo
- Disease:Factor IX deficiency
- Substances:Adeno-Associated Virus Vector Serotype 8 Containing The Human F9 GeneMessenger RNA encoding CAS9+1
Countries:
France
France- Participants:18–64 years · 65+ years
- Substances:Adeno-Associated Virus Vector Serotype 8 Containing The Human F9 Gene




